their term payment, the Company set the net unrealized values at 0.13 million baht. The Company recorded the allowance for doubtful account for only debtors who were overdue. The Company would consider at
to Baht 7.72 million, decrease Baht 0.59 million or decrease 7.62%, this is due to the company set measures to control appropriate spending. 4. Administrative expenses For nine months ended September
November 13, 2017 The President & Director, The Stock Exchange of Thailand (SET) LETTER OF CLARIFICTION: CENTEL’s Q3/2017 & YTD 9 MONTHS /2017 OPERATING PERFORMANCE RESULTS This is to inform the SET
compare with the previous year amount to Baht 10.08 million, decrease Baht 0.12 million or decrease 1.17%, this is due to the company set measure to control appropriate spending. 4. Administrative expenses
) was thus equal to 3.32 percent, decreasing over-quarter, but still within the set target of 3.30-3.50 percent. Moreover, other operating expenses rose Baht 21 million or 0.13 percent over-year, due
Page 1 of 4 No. RJH – SET 11/2019 13 August 2019 Subject : Management’s Discussion and Analysis for the 2nd Quarter of 2019 To : The President The Stock Exchange of Thailand Rajthanee Hospital Public
, travelling aboard were not allowed. - The meeting with external parties in person were not allowed, conference call or online meeting was applied instead. - Approving to the change of appropriate working time
, Samutsakhon 74000 No. DOD43/2563 May 14, 2020 To: The President The Stock Exchange of Thailand (SET) Subject: Management’s Discussion and Analysis for the first Quarter of 2020 DOD Biotech Public Company
second quarter ended June 30, 2020 which the details are as follows: Unit: million Baht For 3-month period (Apr-Jun) 2020 2019 Change % Increase (Decrease) Revenue from sale of goods 128.52 164.02 (35.50
November 11, 2020 Subject: Management’s Discussion and Analysis for the third quarter of 2020 To: The President The Stock Exchange of Thailand (SET) DOD Biotech Public Company Limited and its subsidiaries